<DOCUMENT>
<TYPE>EX-10.43
<SEQUENCE>8
<FILENAME>a2105469zex-10_43.htm
<DESCRIPTION>EX-10.43
<TEXT>
<HTML>
<HEAD>

</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#03MOC1141_7">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>
<!-- TOC_END -->
<P ALIGN="RIGHT"><FONT SIZE=2><A
NAME="la1142_exhibit_10.43"> </A>
<A NAME="toc_la1142_1"> </A>
<BR></FONT><FONT SIZE=2><B>Exhibit 10.43    <BR>  </B></FONT></P>

<P><FONT SIZE=4><B>Long-Term Stock Incentive<BR>
Compensation Program<BR>
(as amended and restated May&nbsp;8, 2002)  </B></FONT></P>

<P><FONT SIZE=3>Edwards Lifesciences Corporation </FONT></P>

<P><FONT SIZE=3>May&nbsp;2002 </FONT></P>

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=1,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=682176,FOLIO='blank',FILE='DISK006:[03MOC2.03MOC1142]LA1142A.;4',USER='TCHAN',CD='14-MAR-2003;04:57' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<!-- TOC_END -->

<P><FONT SIZE=2><A
NAME="lb1142_contents"> </A>
<A NAME="toc_lb1142_1"> </A>
<BR></FONT><FONT SIZE=2><B>Contents    <BR>  </B></FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="78%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2>Article&nbsp;1. Establishment, Objectives, and Duration</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2>1</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;2. Definitions</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
1</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;3. Administration</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
4</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;4. Eligibility and Participation</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
4</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;5. Shares Subject to the Program and Maximum Awards</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
4</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;6. Stock Options</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
6</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;7. Restricted Stock</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
7</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;8. Performance Units and Performance Shares</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
8</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;9. Performance Measures</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
10</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;10. Beneficiary Designation</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
10</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;11. Deferrals</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
11</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;12. Rights of Employees and Contractors</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
11</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;13. Change in Control</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
11</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;14. Amendment, Modification, and Termination</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
11</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;15. Compliance with Applicable Law and Withholding</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
12</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;16. Indemnification</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
13</FONT></TD>
</TR>
<TR BGCOLOR="#CCEEFF" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;17. Successors</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
13</FONT></TD>
</TR>
<TR BGCOLOR="White" VALIGN="TOP">
<TD WIDTH="94%"><FONT SIZE=2><BR>
Article&nbsp;18. Legal Construction</FONT></TD>
<TD WIDTH="3%"><FONT SIZE=2><BR>&nbsp;</FONT></TD>
<TD WIDTH="4%" ALIGN="RIGHT"><FONT SIZE=2><BR>
13</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=2,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=821859,FOLIO='blank',FILE='DISK006:[03MOC2.03MOC1142]LB1142A.;3',USER='JBELANG',CD='13-MAR-2003;00:18' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_lc1142_1_1"> </A> </FONT></P>

<!-- TOC_END -->

<P><FONT SIZE=4><B>Edwards Lifesciences Corporation<BR>
Long-Term Stock Incentive Compensation Program<BR>
(as amended and restated May&nbsp;8, 2002)</B></FONT></P>

<P><FONT SIZE=4><A
NAME="lc1142_article_1._establishment,_objectives,_and_duration"> </A>
<A NAME="toc_lc1142_1"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;1. Establishment, Objectives, and Duration    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>1.1&nbsp;&nbsp;&nbsp;&nbsp;Establishment of the Program.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;Edwards Lifesciences Corporation, a Delaware corporation (hereinafter referred
to as the "Company"), hereby amends and restates the incentive compensation plan established April&nbsp;1, 2000 and known as the "Edwards Lifesciences Corporation Long-Term Stock
Incentive Compensation Program" (hereinafter, as amended and restated, referred to as the "Program"), as set forth in this document. The Program permits the grant of Nonqualified Stock Options,
Incentive Stock Options, Restricted Stock, Performance Shares, and Performance Units. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Program became effective as of April&nbsp;1, 2000 (the "Effective Date") and shall remain in effect as provided in Section&nbsp;1.3 hereof. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Program was amended and restated effective as of July&nbsp;12, 2000 to clarify the definition of "Subsidiary" and was subsequently further amended and restated as of May&nbsp;8,
2002. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>1.2&nbsp;&nbsp;&nbsp;&nbsp;Objectives of the Program.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The objectives of the Program are to optimize the profitability and growth of the
Company through long-term incentives which are consistent with the Company's goals and which link the personal interests of Participants to those of the Company's stockholders; to provide
Participants with an incentive for excellence in individual performance; and to promote teamwork among Participants. Awards generally are made in conjunction with services performed by the Participant
within the previous twelve (12)&nbsp;months. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Program is further intended to provide flexibility to the Company in its ability to motivate, attract, and retain the services of Participants who make significant contributions to
the Company's success and to allow Participants to share in the success of the Company. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>1.3&nbsp;&nbsp;&nbsp;&nbsp;Duration of the Program.</B></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;The Program shall commence on the Effective Date, as described in
Section&nbsp;1.1 hereof, and shall remain in effect, subject to the right of the Board to amend or terminate the Program at any time pursuant to Article&nbsp;14 hereof, until all Shares subject to
it shall have been purchased or acquired according to the Program's provisions. However, in no event may an Award be granted under the Program on or after April&nbsp;1, 2010. </FONT></P>

<P><FONT SIZE=2><A
NAME="lc1142_article_2._definitions"> </A>
<A NAME="toc_lc1142_2"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;2. Definitions    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Whenever used in the Program, the following terms shall have the meanings set forth below, and when the meaning is intended, the initial letter of the word shall
be capitalized: </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.1&nbsp;&nbsp;&nbsp;&nbsp;"Award"</B></FONT><FONT SIZE=2> means, individually or collectively, a grant under this Program of Nonqualified Stock Options, Incentive Stock
Options, Restricted Stock, Performance Shares, or Performance Units. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.2&nbsp;&nbsp;&nbsp;&nbsp;"Award Agreement"</B></FONT><FONT SIZE=2> means an agreement entered into by the Company and each Participant setting forth the terms and
provisions applicable to Awards granted under this Program. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.3&nbsp;&nbsp;&nbsp;&nbsp;"Board"</B></FONT><FONT SIZE=2> or </FONT><FONT SIZE=2><B>"Board of Directors"</B></FONT><FONT SIZE=2> means the Board of Directors of the
Company. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.4&nbsp;&nbsp;&nbsp;&nbsp;"Change in Control"</B></FONT><FONT SIZE=2> of the Company shall mean the occurrence of any one of the following events: </FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(a)</FONT></DT><DD><FONT SIZE=2>Any
"Person", as such term is used in Sections 13(d) and 14(d) of the Exchange Act (other than the Company, any corporation owned, directly or indirectly, by the stockholders of the
Company in substantially the same proportions as their ownership of stock of the Company, and any trustee or other fiduciary holding securities under an employee benefit plan of the Company or such
proportionately owned corporation), is or becomes the "beneficial owner" (as defined in Rule&nbsp;13d-3 under the Exchange Act), directly or indirectly, of securities of the </FONT></DD></DL>
</UL>
<P ALIGN="CENTER"><FONT SIZE=2>1</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=3,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=905917,FOLIO='1',FILE='DISK006:[03MOC2.03MOC1142]LC1142A.;5',USER='JBELANG',CD='12-MAR-2003;23:21' -->
<A NAME="page_lc1142_1_2"> </A>
<UL>
<UL>

<P><FONT SIZE=2>Company
representing thirty percent (30%) or more of the combined voting power of the Company's then outstanding securities; or </FONT></P>

</UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(b)</FONT></DT><DD><FONT SIZE=2>During
any period of not more than twenty-four (24)&nbsp;months, individuals who at the beginning of such period constitute the Board of Directors of the Company, and
any new director (other than a director designated by a Person who has entered into an agreement with the Company to effect a transaction described in Sections 2.4(a), 2.4(c), or 2.4(d) of this
Section&nbsp;2.4) whose election by the Board or nomination for election by the Company's stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in
office who either were directors at the beginning of the
period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority thereof; or
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(c)</FONT></DT><DD><FONT SIZE=2>The
consummation of a merger or consolidation of the Company with any other entity, other than: (i)&nbsp;a merger or consolidation which would result in the voting securities of the
Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than sixty percent
(60%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or (ii)&nbsp;a merger or consolidation
effected to implement a recapitalization of the Company (or similar transaction) in which no Person acquires more than thirty percent (30%) of the combined voting power of the Company's then
outstanding securities; or
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(d)</FONT></DT><DD><FONT SIZE=2>The
Company's stockholders approve a plan of complete liquidation or dissolution of the Company, or an agreement for the sale or disposition by the Company of all or substantially all
of the Company's assets (or any transaction having a similar effect). </FONT></DD></DL>
</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.5&nbsp;&nbsp;&nbsp;&nbsp;"Code"</B></FONT><FONT SIZE=2> means the Internal Revenue Code of 1986, as amended from time to time. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.6&nbsp;&nbsp;&nbsp;&nbsp;"Committee"</B></FONT><FONT SIZE=2> means the Compensation Committee or any other committee appointed by the Board to administer Awards to
Participants, as specified in Article&nbsp;3 herein. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.7&nbsp;&nbsp;&nbsp;&nbsp;"Company"</B></FONT><FONT SIZE=2> means Edwards Lifesciences Corporation, a Delaware corporation, and any successor thereto as provided in
Article&nbsp;17 herein. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.8&nbsp;&nbsp;&nbsp;&nbsp;"Contractor"</B></FONT><FONT SIZE=2> means an individual providing services to the Company who is not an Employee or member of the Board, and who
does not participate in the Edwards Lifesciences Corporation Nonemployee Directors and Consultants Stock Incentive Program. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.9&nbsp;&nbsp;&nbsp;&nbsp;"Covered Employee"</B></FONT><FONT SIZE=2> means a Participant who is one of the group of "covered employees," as defined in the regulations
promulgated under Code Section&nbsp;162(m), or any successor statute. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.10&nbsp;&nbsp;&nbsp;&nbsp;"Disability"</B></FONT><FONT SIZE=2> shall have the meaning ascribed to such term in the Participant's governing long-term
disability plan, or if no such plan exists, at the discretion of the Board. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.11&nbsp;&nbsp;&nbsp;&nbsp;"Effective Date"</B></FONT><FONT SIZE=2> shall have the meaning ascribed to such term in Section&nbsp;1.1 hereof. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.12&nbsp;&nbsp;&nbsp;&nbsp;"Employee"</B></FONT><FONT SIZE=2> means any employee of the Company or of a Subsidiary of the Company. Directors who are employed by the
Company shall be considered Employees under this Program. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.13&nbsp;&nbsp;&nbsp;&nbsp;"Exchange Act"</B></FONT><FONT SIZE=2> means the Securities Exchange Act of 1934, as amended from time to time, or any successor act thereto. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.14&nbsp;&nbsp;&nbsp;&nbsp;"Fair Market Value"</B></FONT><FONT SIZE=2> means, at any date, the closing sale price on the principal securities exchange on which the Shares
are traded on the last previous day on which a sale was reported. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.15&nbsp;&nbsp;&nbsp;&nbsp;"Incentive Stock Option"</B></FONT><FONT SIZE=2> or </FONT><FONT SIZE=2><B>"ISO"</B></FONT><FONT SIZE=2> means an option to purchase Shares
granted under Article&nbsp;6 herein and which is designated as an Incentive Stock Option and which is intended to meet the requirements of Code Section&nbsp;422. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.16&nbsp;&nbsp;&nbsp;&nbsp;"Insider"</B></FONT><FONT SIZE=2> shall mean an individual who is, on the relevant date, an officer, director, or beneficial owner of more than
ten percent (10%) of any class of the Company's equity securities that is </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=4,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=89540,FOLIO='2',FILE='DISK006:[03MOC2.03MOC1142]LC1142A.;5',USER='JBELANG',CD='12-MAR-2003;23:21' -->
<A NAME="page_lc1142_1_3"> </A>
<BR>

<P><FONT SIZE=2>
registered pursuant to Section&nbsp;12 of the Exchange Act, all as defined under Section&nbsp;16 of the Exchange Act. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.17&nbsp;&nbsp;&nbsp;&nbsp;"Nonqualified Stock Option"</B></FONT><FONT SIZE=2> or </FONT><FONT SIZE=2><B>"NQSO"</B></FONT><FONT SIZE=2> means an option to purchase Shares
granted under Article&nbsp;6 herein and which is not intended to meet the requirements of Code Section&nbsp;422. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.18&nbsp;&nbsp;&nbsp;&nbsp;"Option"</B></FONT><FONT SIZE=2> means an Incentive Stock Option or a Nonqualified Stock Option, as described in Article&nbsp;6 herein. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.19&nbsp;&nbsp;&nbsp;&nbsp;"Option Price"</B></FONT><FONT SIZE=2> means the price at which a Share may be purchased by a Participant pursuant to an Option. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.20&nbsp;&nbsp;&nbsp;&nbsp;"Participant"</B></FONT><FONT SIZE=2> means an Employee or Contractor who has been selected to receive an Award or who has outstanding an Award
granted under the Program. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.21&nbsp;&nbsp;&nbsp;&nbsp;"Performance-Based Exception"</B></FONT><FONT SIZE=2> means the performance-based exception from the tax deductibility limitations of Code
Section&nbsp;162(m) applicable to compensation payable to Covered Employees. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.22&nbsp;&nbsp;&nbsp;&nbsp;"Performance Share"</B></FONT><FONT SIZE=2> means an Award granted to a Participant, as described in Article&nbsp;8 herein. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.23&nbsp;&nbsp;&nbsp;&nbsp;"Performance Unit"</B></FONT><FONT SIZE=2> means an Award granted to a Participant, as described in Article&nbsp;8 herein. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.24&nbsp;&nbsp;&nbsp;&nbsp;"Period of Restriction"</B></FONT><FONT SIZE=2> means the period during which the transfer of Shares of Restricted Stock is limited in some way
(based on the passage of time, the achievement of performance goals, or upon the occurrence of other events as determined by the Committee, in its discretion), and the Shares are subject to a
substantial risk of forfeiture, as provided in Article&nbsp;7 herein. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.25&nbsp;&nbsp;&nbsp;&nbsp;"Restricted Stock"</B></FONT><FONT SIZE=2> means an Award granted to a Participant pursuant to Article&nbsp;7 herein. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.26&nbsp;&nbsp;&nbsp;&nbsp;"Retirement"</B></FONT><FONT SIZE=2> means, unless otherwise defined in the applicable Award Agreement, any termination of an Employee's
employment or a Contractor's service after age fifty-five (55)&nbsp;other than due to death, Disability or, with respect to Awards made on or after May&nbsp;8, 2002, Cause, provided
that such Employee or Contractor has at least a combined ten (10)&nbsp;years of service with the Company and Baxter International&nbsp;Inc. A Participant's number of years of service with the
Company and Baxter International&nbsp;Inc. shall be determined by calculating the number of complete twelve-month (12)&nbsp;periods of employment from the Participant's original date of hire as an
Employee or Contractor with the Company or Baxter International&nbsp;Inc. to the Participant's date of employment or service termination. Employment or service with Baxter International&nbsp;Inc.
shall be included for purposes of determining qualification for Retirement only to the extent that such employment or service immediately, and without any break, precedes employment or service with
the Company. For purposes of this definition, unless defined otherwise in the applicable Award Agreement, "Cause" means: (a)&nbsp;a Participant's willful and continued failure to substantially
perform his duties with the Company or a Subsidiary (other than any such failure resulting from Disability); (b)&nbsp;a Participant's willfully engaging in conduct that is demonstrably and
materially injurious to the Company or a Subsidiary, monetarily or otherwise; or (c)&nbsp;a Participant's having been convicted of a felony. For the purpose of determining "Cause," no act, or
failure to act, on a Participant's part shall be deemed "willful" unless done, or omitted to be done, by the Participant not in good faith and without reasonable belief that the action or omission was
in the best interests of the Company or a Subsidiary. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.27&nbsp;&nbsp;&nbsp;&nbsp;"Shares"</B></FONT><FONT SIZE=2> means the shares of common stock of the Company. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>2.28&nbsp;&nbsp;&nbsp;&nbsp;"Subsidiary"</B></FONT><FONT SIZE=2> means any business, whether or not incorporated, in which the Company beneficially owns, directly or
indirectly through another entity or entities, securities or interests representing more than fifty percent (50%) of the combined voting power of the voting securities or voting interests of such
business. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>3</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=3,SEQ=5,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=103061,FOLIO='3',FILE='DISK006:[03MOC2.03MOC1142]LC1142A.;5',USER='JBELANG',CD='12-MAR-2003;23:21' -->
<A NAME="page_lc1142_1_4"> </A>
<BR>

<P><FONT SIZE=2><A
NAME="lc1142_article_3._administration"> </A>
<A NAME="toc_lc1142_3"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;3. Administration    <BR>  </B></FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>3.1&nbsp;&nbsp;&nbsp;&nbsp;General</B></FONT><FONT SIZE=2>. The Program shall be administered by the Compensation Committee of the Board, or by any other Committee
appointed by the Board, which shall consist of two (2)&nbsp;or more nonemployee directors within the meaning of the rules promulgated by the Securities and Exchange Commission under
Section&nbsp;16 of the Exchange Act who also qualify as outside directors within the meaning of Code Section&nbsp;162(m) and the related regulations under the Code, except as otherwise determined
by the Board. Any Committee administering the Program shall be comprised entirely of directors. The members of the Committee shall be appointed from time to time by, and shall serve at the sole
discretion of, the Board. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Committee shall have the authority to delegate administrative duties to officers, Employees, or directors of the Company; provided, however, that the Committee shall not be able to
delegate its authority with respect to: (i)&nbsp;granting Awards to Insiders; (ii)&nbsp;granting Awards that are intended to qualify for the Performance-Based Exception; and
(iii)&nbsp;certifying that any performance goals and other material terms attributable to Awards that are intended to qualify for the Performance-Based Exception have been satisfied. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>3.2&nbsp;&nbsp;&nbsp;&nbsp;Authority of the Committee</B></FONT><FONT SIZE=2>. Except as limited by law or by the Certificate of Incorporation or Bylaws of the Company, and
subject to the provisions of the Program, the Committee shall have the authority to: (a)&nbsp;interpret the provisions of the Program, and prescribe, amend, and rescind rules and procedures relating
to the Program; (b)&nbsp;grant Awards under the Program, in such forms and amounts and subject to such terms and conditions as it deems appropriate, including, without limitation, Awards which are
made in combination with or in tandem with other Awards (whether or not contemporaneously granted) or compensation or in lieu of current or deferred compensation; (c)&nbsp;subject to
Article&nbsp;14, modify the terms of, cancel and reissue, or repurchase outstanding Awards; (d)&nbsp;prescribe the form of agreement, certificate, or other instrument evidencing any Award under
the Program; (e)&nbsp;correct any defect or omission and reconcile any inconsistency in the Program or in any Award hereunder; (f)&nbsp;to design Awards to satisfy requirements to make such Awards
tax-advantaged to Participants in any jurisdiction or for any other reason that the Company desires; and (g)&nbsp;make all other determinations and take all other actions as it deems
necessary or desirable for the administration of the Program; provided, however, that it is the Company's intent that no outstanding Option will be canceled for the purpose of reissuing such Option to
a Participant at a lower exercise price. The determination of the Committee on matters within its authority shall be conclusive and binding on the Company and all other persons. The Committee shall
comply with all applicable laws in administering the Plan. As permitted by law (and subject to Section&nbsp;3.1 herein), the Committee may delegate its authority as identified herein. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>3.3&nbsp;&nbsp;&nbsp;&nbsp;Decisions Binding</B></FONT><FONT SIZE=2>. All determinations and decisions made by the Committee pursuant to the provisions of the Program and
all related orders and resolutions of the Board shall be final, conclusive, and binding on all persons, including the Company, its stockholders, directors, Employees, Contractors, Participants, and
their estates and beneficiaries. </FONT></P>

<P><FONT SIZE=2><A
NAME="lc1142_article_4._eligibility_and_participation"> </A>
<A NAME="toc_lc1142_4"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;4. Eligibility and Participation    <BR>  </B></FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>4.1&nbsp;&nbsp;&nbsp;&nbsp;Eligibility</B></FONT><FONT SIZE=2>. Persons eligible to participate in this Program shall include all Employees and Contractors. Directors who
are not Employees of the Company shall not be eligible to participate in the Program. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>4.2&nbsp;&nbsp;&nbsp;&nbsp;Actual Participation</B></FONT><FONT SIZE=2>. Subject to the provisions of the Program, the Committee may, from time to time, select from all
eligible Employees and Contractors those to whom Awards shall be granted and shall determine the nature and amount of each Award. </FONT></P>


<P><FONT SIZE=2><A
NAME="lc1142_article_5._shares_subje__lc102327"> </A>
<A NAME="toc_lc1142_5"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;5. Shares Subject to the Program and Maximum Awards    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>5.1&nbsp;&nbsp;&nbsp;&nbsp;Number of Shares Available for Grants</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Subject to adjustment as provided in Section&nbsp;5.4 herein, the
number of Shares hereby reserved for delivery to Participants under the Program shall be </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>4</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=4,SEQ=6,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=766939,FOLIO='4',FILE='DISK006:[03MOC2.03MOC1142]LC1142A.;5',USER='JBELANG',CD='12-MAR-2003;23:21' -->
<A NAME="page_lc1142_1_5"> </A>

<P><FONT SIZE=2>
twelve million five hundred thousand (12,500,000) Shares. No more than five hundred thousand (500,000) Shares reserved for issuance under the Program may be granted in the form of Shares of
Restricted Stock. The Committee shall determine the appropriate methodology for calculating the number of Shares issued pursuant to the Program. The following rules shall apply to grants of such
Awards under the Program: </FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(a)</FONT></DT><DD><FONT SIZE=2><B>Options</B></FONT><FONT SIZE=2>: The maximum aggregate number of Shares that may be granted in the form of Options in any one (1)&nbsp;fiscal year to any one
(1)&nbsp;Participant shall be one million (1,000,000).
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(b)</FONT></DT><DD><FONT SIZE=2><B>Restricted Stock</B></FONT><FONT SIZE=2>: The maximum aggregate number of Shares that may be granted in the form of Restricted Stock in any one
(1)&nbsp;fiscal year to any one (1)&nbsp;Participant shall be fifty thousand (50,000).
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(c)</FONT></DT><DD><FONT SIZE=2><B>Performance Shares</B></FONT><FONT SIZE=2>: The maximum aggregate payout (determined as of the end of the applicable performance period) with respect to Awards
of Performance Shares granted in any one (1)&nbsp;fiscal year to any one (1)&nbsp;Participant shall be equal to the value of one hundred thousand (100,000) Shares.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(d)</FONT></DT><DD><FONT SIZE=2><B>Performance Units</B></FONT><FONT SIZE=2>: The maximum aggregate payout (determined as of the end of the applicable performance period) with respect to Awards
of Performance Units granted in any one (1)&nbsp;fiscal year to any one (1)&nbsp;Participant shall be equal to two million dollars ($2,000,000). </FONT></DD></DL>
</UL>
<BR>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>5.2&nbsp;&nbsp;&nbsp;&nbsp;Type of Shares</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Shares issued under the Program in connection with Stock Options and Performance Shares may
be authorized and unissued Shares or issued Shares held as treasury Shares. Shares issued under the Program in connection with Restricted Stock shall be issued Shares held as treasury Shares;
provided, however, that authorized and unissued Shares may be issued in connection with Restricted Stock to the extent that the Committee determines that past services of the Participant constitute
adequate consideration for at least the par value thereof. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>5.3&nbsp;&nbsp;&nbsp;&nbsp;Reuse of Shares</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(a)</FONT></DT><DD><FONT SIZE=2><B>General</B></FONT><FONT SIZE=2>. In the event of the exercise or termination (by reason of forfeiture, expiration, cancellation, surrender, or otherwise) of
any Award under the Program, that number of Shares that was subject to the Award but not delivered shall again be available as Awards under the Program.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(b)</FONT></DT><DD><FONT SIZE=2><B>Restricted Stock</B></FONT><FONT SIZE=2>. In the event that Shares are delivered under the Program as Restricted Stock and are thereafter forfeited or
reacquired by the Company pursuant to rights reserved upon the grant thereof, such forfeited or reacquired Shares shall again be available as Awards under the Program.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(c)</FONT></DT><DD><FONT SIZE=2><B>Limitation</B></FONT><FONT SIZE=2>. Notwithstanding the provisions of Sections 5.3(a) or 5.3(b) above, the following Shares shall not be available for
reissuance under the Program: (i)&nbsp;Shares which are withheld from any Award or payment under the Program to satisfy tax withholding obligations; (ii)&nbsp;Shares which are surrendered to
fulfill tax obligations incurred under the Program; and (iii)&nbsp;Shares which are surrendered in payment of the Option Price upon the exercise of an Option. </FONT></DD></DL>
</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>5.4&nbsp;&nbsp;&nbsp;&nbsp;Adjustments in Authorized Shares</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;In the event of any change in corporate capitalization, such as a stock
split, or a corporate transaction, such as any merger, consolidation, separation, including a spin-off, or other distribution of stock or property of the Company, any reorganization
(whether or not such reorganization comes within the definition of such term in Code Section&nbsp;368) or any partial or complete liquidation of the Company, such adjustment shall be made in the
number and class of Shares which may be delivered under Section&nbsp;5.1, in the number and class of and/or price of Shares subject to outstanding Awards granted under the Program, and in the Award
limits set forth in Section&nbsp;5.1, as shall be determined to be appropriate and equitable by the Committee, in its sole discretion, to prevent dilution or enlargement of rights; provided,
however, that the number of Shares subject to any Award shall always be a whole number. In a stock-for-stock acquisition of the Company, the Committee may, in its sole
discretion, substitute securities of another issuer for any Shares subject to outstanding Awards. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>5</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=5,SEQ=7,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=1020363,FOLIO='5',FILE='DISK006:[03MOC2.03MOC1142]LC1142A.;5',USER='JBELANG',CD='12-MAR-2003;23:21' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2><A
NAME="page_ld1142_1_6"> </A> </FONT></P>

<!-- TOC_END -->

<P><FONT SIZE=2><A
NAME="ld1142_article_6._stock_options"> </A>
<A NAME="toc_ld1142_1"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;6. Stock Options    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>6.1&nbsp;&nbsp;&nbsp;&nbsp;Grant of Options</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Subject to the terms and provisions of the Program, Options may be granted to Participants
in such number, and upon such terms, and at any time and from time to time as shall be determined by the Committee. If all or any portion of the exercise price or taxes incurred in connection with the
exercise are paid by delivery (or, in the case of payment of taxes, by withholding of Shares) of other Shares of the Company, the Options may provide for the grant of replacement Options. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>6.2&nbsp;&nbsp;&nbsp;&nbsp;Award Agreement</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Each Option grant shall be evidenced by an Award Agreement that shall specify the Option
Price, the duration of the Option, the number of Shares to which the Option pertains, and such other provisions as the Committee shall determine. The Award Agreement also shall specify whether the
Option is intended to be an ISO or an NQSO. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>6.3&nbsp;&nbsp;&nbsp;&nbsp;Option Price</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;The Option Price for each grant of an Option under this Program shall be at least equal to one
hundred percent (100%) of the Fair Market Value of a Share on the date the Option is granted. The only exception to the foregoing shall be for Options issued to Participants upon the conversion of
their Baxter International&nbsp;Inc. stock options at the time of the Company's spin-off from Baxter International&nbsp;Inc. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>6.4&nbsp;&nbsp;&nbsp;&nbsp;Duration of Options</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Each Option granted to a Participant shall expire at such time as the Committee shall
determine at the time of grant; provided, however, that no Option shall be exercisable later than the tenth (10th) anniversary date of its grant. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>6.5&nbsp;&nbsp;&nbsp;&nbsp;Exercise of Options</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Options granted under this Article&nbsp;6 shall be exercisable at such times and be
subject to such restrictions and conditions as the Committee shall in each instance approve, which need not be the same for each grant or for each Participant. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>6.6&nbsp;&nbsp;&nbsp;&nbsp;Payment</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Options granted under this Article&nbsp;6 shall be exercised by the delivery of a written notice
(or such other form of notice as the Company may specify) of exercise to the Company, setting forth the number of Shares with respect to which the Option is to be exercised, accompanied by full
payment for the Shares (or a satisfactory "cashless exercise" notice). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Option Price upon exercise of any Option shall be payable to the Company in full either: (a)&nbsp;in cash or its equivalent; (b)&nbsp;by tendering previously acquired Shares (by
either actual delivery or attestation) having an aggregate Fair Market Value at the time of exercise equal to the total Option Price (provided that the Shares which are tendered must have been held by
the Participant for at least six (6)&nbsp;months, or such shorter or longer period, if any, as is necessary to avoid variable accounting treatment); (c)&nbsp;by a cashless exercise, as permitted
under Federal Reserve Board's Regulation&nbsp;T, subject to applicable securities law restrictions and such procedures and limitations as the Company may specify from time to time, (d)&nbsp;by any
other means which the Committee determines to be consistent with the Program's purpose and applicable law, or (e)&nbsp;by a combination of two or more of (a)&nbsp;through (d). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to any governing rules or regulations, including cashless exercise procedures, as soon as practicable after receipt of a notification of exercise and full payment (or a
satisfactory "cashless exercise" notice), the Company shall cause to be issued and delivered to the Participant, in certificate form or otherwise, evidence of the Shares purchased under the Option(s). </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>6.7&nbsp;&nbsp;&nbsp;&nbsp;Restrictions on Share Transferability</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;The Committee may impose such restrictions on any Shares acquired
pursuant to the exercise of an Option granted under this Article&nbsp;6 as it may deem advisable, including, without limitation, restrictions under applicable federal securities laws, under the
requirements of any stock exchange or market upon which such Shares are then listed and/or traded, and under any blue sky or state securities laws applicable to such Shares. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>6</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=8,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=666633,FOLIO='6',FILE='DISK006:[03MOC2.03MOC1142]LD1142A.;2',USER='YLEE',CD='12-MAR-2003;20:39' -->
<A NAME="page_ld1142_1_7"> </A>
<BR>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>6.8&nbsp;&nbsp;&nbsp;&nbsp;Termination of Employment or Service</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Each Participant's Option Award Agreement shall set forth the extent
to which the Participant shall have the right to exercise the Option following termination of the Participant's employment with the Company or service to the Company as a Contractor. Such provisions
shall be determined in the sole discretion of the Committee, shall be included in the Award Agreement entered into with each Participant, need not be uniform among all Options issued pursuant to this
Article&nbsp;6, and may reflect distinctions based on the reasons for termination. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>6.9&nbsp;&nbsp;&nbsp;&nbsp;Nontransferability of Options</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(a)</FONT></DT><DD><FONT SIZE=2><B>Incentive Stock Options</B></FONT><FONT SIZE=2>. No ISO granted under the Program may be sold, transferred, pledged, assigned, or otherwise alienated or
hypothecated, other than by will or by the laws of descent and
distribution. Further, all ISOs granted to a Participant under the Program shall be exercisable during his or her lifetime only by such Participant.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(b)</FONT></DT><DD><FONT SIZE=2><B>Nonqualified Stock Options</B></FONT><FONT SIZE=2>. Except as otherwise provided in a Participant's Award Agreement, no NQSO granted under this
Article&nbsp;6 may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution. Further, except as otherwise
provided in a Participant's Award Agreement, all NQSOs granted to a Participant under this Article&nbsp;6 shall be exercisable during his or her lifetime only by such Participant. </FONT></DD></DL>
</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>6.10&nbsp;&nbsp;&nbsp;&nbsp;Substitution of Cash</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise provided in a Participant's Award Agreement, and notwithstanding any
provision in the Program to the contrary (including but not limited to Section&nbsp;14.2), in the event of a Change in Control in which the Company's stockholders holding Shares receive
consideration other than shares of common stock that are registered under Section&nbsp;12 of the Exchange Act, the Committee shall have the authority to require that any outstanding Option be
surrendered to the Company by a Participant for cancellation by the Company, with the Participant receiving in exchange a cash payment from the Company within ten (10)&nbsp;days of the Change in
Control. Such cash payment shall be equal to the number of Shares under Option, multiplied by the excess, if any, of the greater of (i)&nbsp;the highest per Share price offered to stockholders in
any transaction whereby the Change in Control takes place, or (ii)&nbsp;the Fair Market Value of a Share on the date the Change in Control occurs, over the Option Price. </FONT></P>


<P><FONT SIZE=2><A
NAME="ld1142_article_7._restricted_stock"> </A>
<A NAME="toc_ld1142_2"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;7. Restricted Stock    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>7.1&nbsp;&nbsp;&nbsp;&nbsp;Grant of Restricted Stock</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Subject to the terms and provisions of the Program, the Committee, at any time
and from time to time, may grant Shares of Restricted Stock to Participants in such amounts as the Committee shall determine. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>7.2&nbsp;&nbsp;&nbsp;&nbsp;Restricted Stock Agreement</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Each Restricted Stock grant shall be evidenced by a Restricted Stock Award
Agreement that shall specify the Period(s) of Restriction, the number of Shares of Restricted Stock granted, and such other provisions as the Committee shall determine. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>7.3&nbsp;&nbsp;&nbsp;&nbsp;Restriction on Transferability</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Except as provided in this Article&nbsp;7, the Shares of Restricted Stock
granted herein may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated until the end of the applicable Period of Restriction established by the Committee and specified
in the Restricted Stock Award Agreement, or upon earlier satisfaction of any other conditions, as specified by the Committee in its sole discretion and set forth in the Restricted Stock Award
Agreement. All rights with respect to the Restricted Stock granted to a Participant under the Program shall be available during his or her lifetime only to such Participant. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>7</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=9,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=111235,FOLIO='7',FILE='DISK006:[03MOC2.03MOC1142]LD1142A.;2',USER='YLEE',CD='12-MAR-2003;20:39' -->
<A NAME="page_ld1142_1_8"> </A>
<BR>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>7.4&nbsp;&nbsp;&nbsp;&nbsp;Other Restrictions</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Subject to Article&nbsp;9 herein, the Committee shall impose such other conditions
and/or restrictions on any Shares of Restricted Stock granted pursuant to the Program as it may deem advisable including, without limitation, any or all of the following: </FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(a)</FONT></DT><DD><FONT SIZE=2>A
required period of employment or service as a Contractor with the Company, as determined by the Committee, prior to the vesting of Shares of Restricted Stock.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(b)</FONT></DT><DD><FONT SIZE=2>A
requirement that Participants forfeit (or in the case of Shares sold to a Participant, resell to the Company at his or her cost) all or a part of Shares of Restricted Stock in the
event of termination of his or her employment or service as a Contractor during the Period of Restriction.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(c)</FONT></DT><DD><FONT SIZE=2>A
prohibition against employment of Participants holding Shares of Restricted Stock by any competitor of the Company, against such Participants' dissemination of any secret or
confidential information belonging to the Company, or the solicitation by Participants of the Company's employees for employment by another entity. </FONT></DD></DL>
</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares
of Restricted Stock awarded pursuant to the Program shall be registered in the name of the Participant and, if such Shares are certificated, in the sole discretion of the
Committee, may be deposited in a bank designated by the Committee or with the Company. The Committee may require a stock power endorsed in blank with respect to Shares of Restricted Stock whether or
not certificated. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except
as otherwise provided in this Article&nbsp;7, Shares of Restricted Stock covered by each Restricted Stock grant made under the Program shall become freely transferable (subject
to any restrictions under any applicable securities law) by the Participant after the last day of the applicable Period of Restriction. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>7.5&nbsp;&nbsp;&nbsp;&nbsp;Voting Rights</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Unless the Committee determines otherwise, Participants holding Shares of Restricted Stock
issued hereunder shall be entitled to exercise full voting rights with respect to those Shares during the Period of Restriction. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>7.6&nbsp;&nbsp;&nbsp;&nbsp;Dividends and Other Distributions</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Unless the Committee determines otherwise, during the Period of
Restriction, Participants holding Shares of Restricted Stock issued hereunder shall be entitled to regular cash dividends paid with respect to such Shares. The Committee may apply any restrictions to
the dividends that the Committee deems appropriate. Without limiting the generality of the preceding sentence, if the grant or vesting of Shares of Restricted Stock is designed to comply with the
requirements of the Performance-Based Exception, the Committee may apply any restrictions it deems appropriate to the payment of dividends declared with respect to such Shares of Restricted Stock,
such that the dividends and/or the Shares of Restricted Stock maintain eligibility for the Performance-Based Exception. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>7.7&nbsp;&nbsp;&nbsp;&nbsp;Termination of Employment or Service</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Each Restricted Stock Award Agreement shall set forth the extent to
which the Participant shall have the right to vest in previously unvested Shares of Restricted Stock following termination of the Participant's employment with the Company or service to the Company as
a Contractor. Such provisions shall be determined in the sole discretion of the Committee, shall be included in the Award Agreement entered into with each Participant, need not be uniform among all
Shares of Restricted Stock issued pursuant to the Program, and may reflect distinctions based on the reasons for termination. </FONT></P>


<P><FONT SIZE=2><A
NAME="ld1142_article_8._performance_units_and_performance_shares"> </A>
<A NAME="toc_ld1142_3"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;8. Performance Units and Performance Shares    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>8.1&nbsp;&nbsp;&nbsp;&nbsp;Grant of Performance Units/Shares</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Subject to the terms of the Program, Performance Units and/or Performance
Shares may be granted to Participants in such amounts and upon such terms, and at any time and from time to time, as shall be determined by the Committee. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>8</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=3,SEQ=10,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=860118,FOLIO='8',FILE='DISK006:[03MOC2.03MOC1142]LD1142A.;2',USER='YLEE',CD='12-MAR-2003;20:39' -->
<A NAME="page_ld1142_1_9"> </A>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>8.2&nbsp;&nbsp;&nbsp;&nbsp;Value of Performance Units/Shares</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Each Performance Unit shall have an initial value that is established by
the Committee at the time of grant. Each Performance Share shall have an initial value equal to the Fair Market Value of a Share on the date of grant. The Committee shall set performance goals in its
sole discretion which, depending on the extent to which they are met, will determine the number and/or value of Performance Units/Shares that will be paid out to the Participant. For purposes of this
Article&nbsp;8, the time period during which the performance goals must be met shall be called a "Performance Period." </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>8.3&nbsp;&nbsp;&nbsp;&nbsp;Earning of Performance Units/Shares</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Subject to the terms of this Program, after the applicable Performance
Period has ended, the holder of Performance Units/Shares shall be entitled to receive payout on the number and value of Performance Units/Shares earned by the Participant over the Performance Period,
to be determined as a function of the extent to which the corresponding performance goals have been achieved. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>8.4&nbsp;&nbsp;&nbsp;&nbsp;Form and Timing of Payment of Performance Units/Shares</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Payment of earned Performance Units/Shares shall be
made in a single lump sum following the close of the applicable Performance Period. Subject to the terms of this Program, the Committee, in its sole discretion, may pay earned Performance Units/Shares
in the form of cash or in Shares (or in a combination thereof) which have an aggregate Fair Market Value equal to the value of the earned Performance Units/Shares at the close of the applicable
Performance Period. Such Shares may be granted subject to any restrictions deemed appropriate by the Committee. The determination of the Committee with respect to the form of payout of such Awards
shall be set forth in the Award Agreement pertaining to the grant of the Award. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At
the discretion of the Committee, Participants may be entitled to receive any dividends declared with respect to Shares which have been earned in connection with grants of Performance
Units and/or Performance Shares which have been earned, but not yet distributed to Participants (such dividends shall be subject to the same accrual, forfeiture, and payout restrictions as apply to
dividends earned with respect to Shares of Restricted Stock, as set forth in Section&nbsp;7.6 herein). In addition, Participants may, at the discretion of the Committee, be entitled to exercise
their voting rights with respect to such Shares. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>8.5&nbsp;&nbsp;&nbsp;&nbsp;Termination of Employment or Service Due to Death, Disability, or Retirement</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Unless determined otherwise by
the Committee and set forth in the Participant's Award Agreement, following termination of the Participant's employment with the Company or service to the Company as a Contractor, by reason of death,
Disability, or Retirement during a Performance Period, the Participant or his legal representative shall receive a payout of the Performance Units/Shares which is prorated, as specified by the
Committee in its discretion. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment
of earned Performance Units/Shares shall be made at a time specified by the Committee in its sole discretion and set forth in the Participant's Award Agreement. Notwithstanding
the foregoing, with respect to Covered Employees who retire during a Performance Period, payments shall be made at the same time as payments are made to Participants who did not terminate employment
during the applicable Performance Period. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>8.6&nbsp;&nbsp;&nbsp;&nbsp;Termination of Employment or Service for Other Reasons</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;In the event that a Participant's employment or
service to the Company as a Contractor terminates for any reason other than those reasons set forth in Section&nbsp;8.5 herein, all Performance Units/Shares shall be forfeited by the Participant to
the Company unless determined otherwise by the Committee, as set forth in the Participant's Award Agreement. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>8.7&nbsp;&nbsp;&nbsp;&nbsp;Nontransferability</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided in a Participant's Award Agreement, Performance
Units/Shares may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution. Further, except as otherwise
provided in a Participant's Award Agreement, a Participant's rights under the Program shall be </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>9</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=4,SEQ=11,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=629262,FOLIO='9',FILE='DISK006:[03MOC2.03MOC1142]LD1142A.;2',USER='YLEE',CD='12-MAR-2003;20:39' -->
<A NAME="page_ld1142_1_10"> </A>
<BR>

<P><FONT SIZE=2>
exercisable during the Participant's lifetime only by the Participant or the Participant's legal representative. </FONT></P>

<P><FONT SIZE=2><A
NAME="ld1142_article_9._performance_measures"> </A>
<A NAME="toc_ld1142_4"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;9. Performance Measures    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unless and until the Board proposes for stockholder vote and stockholders approve a change in the general performance measures set forth in this Article&nbsp;9,
the attainment of which may determine the degree of payout and/or vesting with respect to Awards to Covered Employees which are designed to qualify for the Performance-Based Exception, the performance
measure(s) to be used for purposes of such grants shall be chosen from among: </FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(a)</FONT></DT><DD><FONT SIZE=2>Earnings
per share;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(b)</FONT></DT><DD><FONT SIZE=2>Net
income (before or after taxes);
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(c)</FONT></DT><DD><FONT SIZE=2>Return
measures (including, but not limited to, return on assets, capital, equity, or sales);
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(d)</FONT></DT><DD><FONT SIZE=2>Cash
flow return on investments which equals net cash flows divided by owners' equity;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(e)</FONT></DT><DD><FONT SIZE=2>Gross
revenues;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(f)</FONT></DT><DD><FONT SIZE=2>Market-to-book
value ratio;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(g)</FONT></DT><DD><FONT SIZE=2>Share
price (including, but not limited to, growth measures and total shareholder return);
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(h)</FONT></DT><DD><FONT SIZE=2>Working
capital measures;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(i)</FONT></DT><DD><FONT SIZE=2>Economic
value added; and
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(j)</FONT></DT><DD><FONT SIZE=2>The
percentage of sales generated by new products. </FONT></DD></DL>
</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject
to the terms of the Program, each of these measures shall be defined by the Committee on a corporation or subsidiary basis or in comparison with peer group performance, and may
include or exclude specified extraordinary items, as determined by the corporation's auditors. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Committee shall have the discretion to adjust the determinations of the degree of attainment of the preestablished performance goals or the size of Awards; provided, however, that
Awards which are designed to qualify for the Performance-Based Exception, and which are held by Covered Employee, may not be adjusted upward in terms of either the degree of goal attainment or size
(the Committee shall retain the discretion to adjust the degree of goal attainment or the size of the Awards downward). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the event that applicable tax and/or securities laws change to permit Committee discretion to alter the governing performance measures without obtaining stockholder approval of such
changes, the Committee shall have sole discretion to make such changes without obtaining stockholder approval. In addition, in the event that the Committee determines that it is advisable to grant
Awards that shall not qualify for the Performance-Based Exception, the Committee may make such grants without satisfying the requirements of Code Section&nbsp;162(m). </FONT></P>

<P><FONT SIZE=2><A
NAME="ld1142_article_10._beneficiary_designation"> </A>
<A NAME="toc_ld1142_5"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;10. Beneficiary Designation    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Participant under the Program may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any
benefit under the Program is to be paid in case of his or her death before he or she receives any or all of such benefit. Each such designation shall revoke all prior designations by the same
Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing with the Company during the Participant's lifetime. In the absence of any
such designation, benefits remaining unpaid at the Participant's death shall be paid to the Participant's estate. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>10</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=5,SEQ=12,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=196131,FOLIO='10',FILE='DISK006:[03MOC2.03MOC1142]LD1142A.;2',USER='YLEE',CD='12-MAR-2003;20:39' -->
<A NAME="page_ld1142_1_11"> </A>
<BR>

<P><FONT SIZE=2><A
NAME="ld1142_article_11._deferrals"> </A>
<A NAME="toc_ld1142_6"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;11. Deferrals    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Committee may permit or require a Participant to defer such Participant's receipt of the payment of cash or the delivery of Shares that would otherwise be due
to such Participant by virtue of the exercise of an Option, lapse or waiver of restrictions with respect to Restricted Stock, or the satisfaction of any performance goals with respect to Performance
Units/Shares. If any such deferral election is required or permitted, the Committee shall, in its sole discretion, establish rules and procedures for such payment deferrals. </FONT></P>


<P><FONT SIZE=2><A
NAME="ld1142_article_12._rights_of_employees_and_contractors"> </A>
<A NAME="toc_ld1142_7"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;12. Rights of Employees and Contractors    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>12.1&nbsp;&nbsp;&nbsp;&nbsp;Employment</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Nothing in the Program or any Award Agreement shall interfere with or limit in any way the
right of the Company to terminate at any time any Participant's employment or service to the Company as a Contractor, nor confer upon any Participant any right to continue in the employ of the Company
or to provide services to the Company as a Contractor. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>12.2&nbsp;&nbsp;&nbsp;&nbsp;Participation</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;No Employee or Contractor shall have the right to be selected to receive an Award under this
Program, or, having been so selected, to be selected to receive a future Award. </FONT></P>

<P><FONT SIZE=2><A
NAME="ld1142_article_13._change_in_control"> </A>
<A NAME="toc_ld1142_8"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;13. Change in Control    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as may otherwise be provided in a Participant's Award Agreement, upon the occurrence of a Change in Control, unless otherwise specifically prohibited under
applicable laws or by the rules and regulations of any governing governmental agencies or national securities exchanges: </FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(a)</FONT></DT><DD><FONT SIZE=2>Any
and all Options granted hereunder shall become immediately exercisable, and, if granted before May&nbsp;8, 2002, shall remain exercisable throughout their entire term;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(b)</FONT></DT><DD><FONT SIZE=2>Any
restriction periods and restrictions imposed on Shares of Restricted Stock that are not performance-based shall lapse;
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(c)</FONT></DT><DD><FONT SIZE=2>The
vesting of all performance-based Awards denominated in Shares such as performance-based Restricted Stock and Performance Shares shall be accelerated as of the effective date of
the Change in Control, and there shall be paid out to Participants within thirty (30)&nbsp;days following the effective date of the Change in Control a pro rata number of Shares based upon an
assumed achievement of all relevant targeted performance goals and upon the length of time within the Performance Period(s) which has elapsed prior to the Change in Control. The vesting of Awards
denominated in cash, such as Performance Units, shall also be accelerated as of effective date of the Change in Control and there shall be paid out to Participants within thirty (30)&nbsp;days
following the effective date of the Change in Control a pro rata cash payment with the proration determined as a function of the length of time within the Performance Period(s) which has elapsed prior
to the Change in Control, and based on an assumed achievement of all relevant targeted performance goals; provided, however, that if an Option or Share of Restricted Stock granted on or after
May&nbsp;8, 2002 becomes exercisable or vests only after either (i)&nbsp;a minimum fixed period of employment or service (the duration of which is determined by the
Committee at the time of the grant of the Award) or (ii)&nbsp;the earlier achievement of a performance-related goal, its exercisability or vesting shall not automatically accelerate in full in
accordance with Article&nbsp;13 (a)&nbsp;or (b)&nbsp;above, but may accelerate if and to the extent provided in the applicable Award Agreement. </FONT></DD></DL>
</UL>

<P><FONT SIZE=2><A
NAME="ld1142_article_14._amendment,_modification,_and_termination"> </A>
<A NAME="toc_ld1142_9"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;14. Amendment, Modification, and Termination    <BR>  </B></FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>14.1&nbsp;&nbsp;&nbsp;&nbsp;Amendment, Modification, and Termination</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Subject to the terms of the Program, including
Section&nbsp;14.2, the Board may at any time and from time to time, alter, amend, suspend or </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>11</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=6,SEQ=13,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=909404,FOLIO='11',FILE='DISK006:[03MOC2.03MOC1142]LD1142A.;2',USER='YLEE',CD='12-MAR-2003;20:39' -->
<A NAME="page_ld1142_1_12"> </A>

<P><FONT SIZE=2>
terminate the Program in whole or in part and the Committee may amend Awards previously granted under the Program. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>14.2&nbsp;&nbsp;&nbsp;&nbsp;Awards Previously Granted</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any provision of the Program or of any Award Agreement to the
contrary (but subject to Section&nbsp;6.10 hereof), no termination, amendment, or modification of the Program or amendment of an Award previously granted under the Program shall adversely affect in
any material way any Award previously granted under the Program, without the express consent of the Participant holding such Award. </FONT></P>

<P><FONT SIZE=2><A
NAME="ld1142_article_15._compliance___ld102179"> </A>
<A NAME="toc_ld1142_10"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;15. Compliance with Applicable Law and Withholding    <BR>  </B></FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>15.1&nbsp;&nbsp;&nbsp;&nbsp;General</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;The granting of Awards and the issuance of Shares under the Program shall be subject to all
applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required. Notwithstanding anything to the contrary in the Program
or any Award Agreement, the following shall apply: </FONT></P>

<UL>
<DL compact>
<DT style='margin-bottom:-11pt;'><FONT SIZE=2>(a)</FONT></DT><DD><FONT SIZE=2>The
Company shall have no obligation to issue any Shares under the Program if such issuance would violate any applicable law or any applicable regulation or requirement of any
securities exchange or similar entity.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(b)</FONT></DT><DD><FONT SIZE=2>Prior
to the issuance of any Shares under the Program, the Company may require a written statement that the recipient is acquiring the Shares for investment and not for the purpose or
with the
intention of distributing the Shares and that the recipient will not dispose of them in violation of the registration requirements of the Securities Act of 1933.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(c)</FONT></DT><DD><FONT SIZE=2>With
respect to any person who is subject to Section&nbsp;16(a) of the Exchange Act, the Committee may, at any time, add such conditions and limitations to any incentive or payment
under the Program or implement procedures for the administration of the Program which it deems necessary or desirable to comply with the requirements of Rule&nbsp;16b-3 of the Exchange
Act.
<BR><BR></FONT></DD><DT style='margin-bottom:-11pt;'><FONT SIZE=2>(d)</FONT></DT><DD><FONT SIZE=2>If,
at any time, the Company, determines that the listing, registration, or qualification (or any updating of any such document) of any Award, or the Shares issuable pursuant thereto,
is necessary on any securities exchange or under any federal or state securities or blue sky law, or that the consent or approval of any governmental regulatory body is necessary or desirable as a
condition of, or in connection with, any Award, the issuance of Shares pursuant to any Award, or the removal of any restrictions imposed on Shares subject to an Award, such Award shall not be granted
and the Shares shall not be issued or such restrictions shall not be removed, as the case may be, in whole or in part, unless such listing, registration, qualification, consent, or approval shall have
been effected or obtained free of any conditions not acceptable to the Company. </FONT></DD></DL>
</UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>15.2&nbsp;&nbsp;&nbsp;&nbsp;Securities Law Compliance</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;With respect to Insiders, transactions under this Program are intended to comply
with all applicable conditions of Rule&nbsp;16b-3 or its successors under the 1934 Act. To the extent any provision of the Program or action by the Committee or the Board fails to so
comply, it shall be deemed null and void, to the extent permitted by law and deemed advisable by the Board. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>15.3&nbsp;&nbsp;&nbsp;&nbsp;Tax Withholding</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;The Company shall have the power and the right to deduct or withhold, or require a
Participant to remit to the Company, an amount sufficient to satisfy federal, state, local and foreign taxes required by law or regulation to be withheld with respect to any taxable event arising as a
result of this Program. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>15.4&nbsp;&nbsp;&nbsp;&nbsp;Share Withholding</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Awards payable in Shares may provide that with respect to withholding required upon any
taxable event arising thereunder, Participants may elect to satisfy the withholding requirement, in whole or in part, by having the Company withhold Shares to satisfy their withholding </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>12</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=7,SEQ=14,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=1027766,FOLIO='12',FILE='DISK006:[03MOC2.03MOC1142]LD1142A.;2',USER='YLEE',CD='12-MAR-2003;20:39' -->
<A NAME="page_ld1142_1_13"> </A>
<BR>

<P><FONT SIZE=2>
tax obligations; provided that Participants may only elect to have Shares withheld having a Fair Market Value on the date the tax is to be determined equal to or less than the minimum withholding tax
which could be imposed on the transaction. All elections shall be irrevocable, made in writing, signed by the Participant, and shall be subject to any restrictions or limitations, including prior
Committee approval, that the Committee, in its sole discretion, deems appropriate. </FONT></P>

<P><FONT SIZE=2><A
NAME="ld1142_article_16._indemnification"> </A>
<A NAME="toc_ld1142_11"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;16. Indemnification    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each person who is or shall have been a member of the Committee, or of the Board, shall be indemnified and held harmless by the Company against and from any loss,
cost, liability, or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any claim, action, suit, or proceeding to which he or she may be a party
or in which he or she may be involved by reason of any action taken or failure to act under the Program and against and from any and all amounts paid by him or her in settlement thereof, with the
Company's approval, or paid by him or her in satisfaction of any judgment in any such action, suit, or proceeding against him or her, provided he or she shall give the Company an opportunity, at its
own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own behalf. The foregoing right of indemnification shall not be exclusive of any other
rights of indemnification to which such persons may be entitled under the Company's Articles of Incorporation or Bylaws, as a matter of law, or otherwise, or any power that the Company may have to
indemnify them or hold them harmless. </FONT></P>

<P><FONT SIZE=2><A
NAME="ld1142_article_17._successors"> </A>
<A NAME="toc_ld1142_12"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;17. Successors    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All obligations of the Company under the Program with respect to Awards granted hereunder shall, to the extent legally permissible, be binding on any successor to
the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of
the Company. </FONT></P>

<P><FONT SIZE=2><A
NAME="ld1142_article_18._legal_construction"> </A>
<A NAME="toc_ld1142_13"> </A>
<BR></FONT><FONT SIZE=2><B>Article&nbsp;18. Legal Construction    <BR>  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>18.1&nbsp;&nbsp;&nbsp;&nbsp;Gender and Number</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;Except where otherwise indicated by the context, any masculine term used herein also
shall include the feminine; the plural shall include the singular and the singular shall include the plural. </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>18.2&nbsp;&nbsp;&nbsp;&nbsp;Severability</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;In the event any provision of the Program shall be held illegal or invalid for any reason,
the illegality or invalidity shall not affect the remaining parts of the Program, and the Program shall be construed and enforced as if the illegal or invalid provision had not been included. </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT
SIZE=2><B>18.3&nbsp;&nbsp;&nbsp;&nbsp;Governing Law</B></FONT><FONT SIZE=2>.&nbsp;&nbsp;&nbsp;&nbsp;To the extent not preempted by federal law, the Program, and all Award or other agreements
hereunder, shall be construed in accordance with and governed by the laws of the state of Delaware without giving effect to principles of conflicts of laws. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>13</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=8,SEQ=15,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7",CHK=325267,FOLIO='13',FILE='DISK006:[03MOC2.03MOC1142]LD1142A.;2',USER='YLEE',CD='12-MAR-2003;20:39' -->
<BR>
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="03MOC1141_7">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2><A HREF="#toc_la1142_1">Exhibit 10.43</A></FONT><BR>
</UL>
<!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2><A HREF="#toc_lb1142_1">Contents</A></FONT><BR>
</UL>
<!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2><A HREF="#toc_lc1142_1">Article 1. Establishment, Objectives, and Duration</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_lc1142_2">Article 2. Definitions</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_lc1142_3">Article 3. Administration</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_lc1142_4">Article 4. Eligibility and Participation</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_lc1142_5">Article 5. Shares Subject to the Program and Maximum Awards</A></FONT><BR>
</UL>
<!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2><A HREF="#toc_ld1142_1">Article 6. Stock Options</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ld1142_2">Article 7. Restricted Stock</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ld1142_3">Article 8. Performance Units and Performance Shares</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ld1142_4">Article 9. Performance Measures</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ld1142_5">Article 10. Beneficiary Designation</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ld1142_6">Article 11. Deferrals</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ld1142_7">Article 12. Rights of Employees and Contractors</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ld1142_8">Article 13. Change in Control</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ld1142_9">Article 14. Amendment, Modification, and Termination</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ld1142_10">Article 15. Compliance with Applicable Law and Withholding</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ld1142_11">Article 16. Indemnification</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ld1142_12">Article 17. Successors</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ld1142_13">Article 18. Legal Construction</A></FONT><BR>
</UL>
<!-- SEQ=,FILE='QUICKLINK',USER=JHILL,SEQ=,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="7" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>

</TEXT>
</DOCUMENT>
